rs1131691058
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_003000.3(SDHB):c.744C>G(p.Asn248Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N248S) has been classified as Uncertain significance.
Frequency
Consequence
NM_003000.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDHB | NM_003000.3 | c.744C>G | p.Asn248Lys | missense_variant | 7/8 | ENST00000375499.8 | NP_002991.2 | |
SDHB | NM_001407361.1 | c.690C>G | p.Asn230Lys | missense_variant | 7/8 | NP_001394290.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDHB | ENST00000375499.8 | c.744C>G | p.Asn248Lys | missense_variant | 7/8 | 1 | NM_003000.3 | ENSP00000364649.3 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152188Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74352
ClinVar
Submissions by phenotype
Paraganglioma Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Cancer Variant Interpretation Group UK, Institute of Cancer Research, London | Mar 11, 2022 | Data included in classification: Absent from gnomAD (PM2_mod) Phenotype data: UK family #1: Observed in proband with bilateral head and neck paragangliomas (PP4_mod) Revel score >0.7 (0.866) (PP3_sup) Within “hot region” for SDHB as defined in Garrett et al. 2021 (https://doi.org/10.1016/j.gim.2021.08.004). (amino acids 177-260) (PM1_mod) Data not included in classification: Observed in Garrett et al. 2021 (https://doi.org/10.1016/j.gim.2021.08.004). 1/6118 cases (likely same proband from UK family #1) Crystal structure of mitochondrial respiratory membrane protein complex II.Sun F, Huo X, Zhai Y, Wang A, Xu J, Su D, Bartlam M, Rao Z.Cell. 2005 Jul 1;121(7):1043-57.PMID:15989954 - |
Pheochromocytoma;C0238198:Gastrointestinal stromal tumor;C1861848:Paragangliomas 4 Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 15, 2023 | This sequence change replaces asparagine, which is neutral and polar, with lysine, which is basic and polar, at codon 248 of the SDHB protein (p.Asn248Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with paraganglioma (PMID: 18551016, 34906457; Invitae). ClinVar contains an entry for this variant (Variation ID: 428929). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SDHB protein function with a positive predictive value of 80%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Hereditary cancer-predisposing syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 31, 2021 | The p.N248K variant (also known as c.744C>G), located in coding exon 7 of the SDHB gene, results from a C to G substitution at nucleotide position 744. The asparagine at codon 248 is replaced by lysine, an amino acid with similar properties. This alteration has been previously described in multiple individuals diagnosed with paragangliomas and/or pheochromocytomas (Persu A et al. J. Hypertens., 2008 Jul;26:1395-401; Fishbein L et al. Ann Surg Oncol, 2013 May;20:1444-50; Papathomas TG et al. Mod. Pathol., 2015 Jun;28:807-21). Based on internal structural assessment, this variant introduces a positive charge near the quinone-reducing active site and affects the final electron transfer reaction (Sun F et al. Cell, 2005 Jul;121:1043-57; Liu J et al. Chem. Rev., 2014 Apr;114:4366-469). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at